Free Trial

Adaptive Biotechnologies (ADPT) Insider Trading & Ownership

Adaptive Biotechnologies logo
$6.05 -0.47 (-7.21%)
(As of 03:22 PM ET)

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$429,325.41
Get ADPT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Adaptive Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ADPT Insider Buying and Selling by Quarter

Adaptive Biotechnologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2024Kyle PiskelCFOSell248$4.98$1,235.04  
3/5/2024Chad M RobinsCEOSell48,673$3.43$166,948.39  
3/5/2024Julie RubinsteinPresidentSell39,070$3.47$135,572.90  
3/5/2024Kyle PiskelInsiderSell7,727$3.43$26,503.61  
3/5/2024Stacy L TaylorSVPSell13,381$3.43$45,896.83  
3/5/2024Tycho PetersonCFOSell15,456$3.44$53,168.64  
(Data available from 1/1/2013 forward)

ADPT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Adaptive Biotechnologies includes Chad M Cohen, Chad M Robins, Julie Rubinstein, Kyle Piskel, Lance Baldo, Michelle Renee Griffin, Nitin Sood, R Mark Adams, Stacy L Taylor, and Tycho Peterson. Learn more on insiders at ADPT.

6.20% of Adaptive Biotechnologies stock is owned by insiders. Learn more on ADPT's insider holdings.

The following insiders have sold ADPT shares in the last 24 months: Chad M Robins ($166,948.39), Julie Rubinstein ($329,837.66), Kyle Piskel ($59,051.85), Michelle Renee Griffin ($19,875.09), Nitin Sood ($38,320.56), R Mark Adams ($71,355.53), Stacy L Taylor ($92,954.70), and Tycho Peterson ($2,020,931.18).

Insiders have sold a total of 415,797 Adaptive Biotechnologies shares in the last 24 months for a total of $2,799,274.96 sold.

Adaptive Biotechnologies Key Executives



This page (NASDAQ:ADPT) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners